Search people, articles, bills, and more
“Amendment SA 3841 agreed to in Senate by Voice Vote.”
This amendment prevents the Department of Defense from hiring or buying services from specific biotechnology companies that are considered national security risks. By adding this rule to the annual defense bill, it aims to keep sensitive biological data and research out of the hands of foreign competitors.
No reactions yet. Be the first to weigh in.
“Amendment SA 3841 agreed to in Senate by Voice Vote.”
This amendment prevents the Department of Defense from hiring or buying services from specific biotechnology companies that are considered national security risks. By adding this rule to the annual defense bill, it aims to keep sensitive biological data and research out of the hands of foreign competitors.
Biotechnology involves sensitive research and data, such as genetic information. This amendment seeks to ensure that foreign companies deemed a threat cannot access that data through government contracts or use U.S. funding to expand their operations.
This directly affects the Department of Defense and any biotechnology companies identified as security risks, as well as the prime contractors who might have previously hired those companies as subcontractors.